Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
39.55
+1.04 (2.70%)
At close: Sep 14, 2026, 4:00 PM EDT
39.50
-0.05 (-0.13%)
After-hours: Sep 14, 2026, 4:42 PM EDT
Septerna Market Cap
Septerna has a market cap or net worth of $1.85 billion as of September 14, 2026. Its market cap has increased by 189.96% in one year.
Market Cap
1.85B
Enterprise Value
1.35B
1-Year Change
189.96%
Ranking
Category
Stock Price
$39.55
ChartMarket Cap Chart
Since the IPO on October 25, 2024, Septerna's market cap has increased from $756.05M to $1.85B, an increase of 144.17%. That is a compound annual growth rate of 60.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 1.85B | 47.89% |
| Dec 31, 2025 | 1.25B | 22.77% |
| Dec 31, 2024 | 1.02B | 34.49% |
| Oct 25, 2024 | 756.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.87B |
| GH Research | 1.87B |
| Zymeworks | 1.86B |
| Nanobiotix | 1.85B |
| Hemab Therapeutics Holdings | 1.84B |
| Xencor | 1.81B |
| Kailera Therapeutics | 1.81B |
| Vir Biotechnology | 1.80B |